Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 12,390
+280 (2.31%)
Nov 2, 2026, 3:30 PM KST
| Market Cap | 562.60B -31.9% |
| Revenue (ttm) | 82.17B +179.3% |
| Net Income | 24.25B +430.5% |
| EPS | 528.52 +375.6% |
| Shares Out | 45.41M |
| PE Ratio | 23.44 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 99,458 |
| Open | 11,860 |
| Previous Close | 12,110 |
| Day's Range | 11,830 - 12,490 |
| 52-Week Range | 8,790 - 28,900 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 6, 2026 |